ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Black History Month 2022
A series of interviews in celebration of Black History Month, featuring members of the Black community who work within the field of STEM, as we want to allow more diverse voices to be heard and acknowledge their achievements.
Gene therapy – affordability, access and reimbursement
Brian Huber considers the affordability, access and reimbursement challenges within the gene therapy market.
How CRO venture capital relationships can help biotech fundraising
This article considers how partnering with a CRO can help emerging biotechs to secure funding.
JPM 2022: Decentralised trials, broader service offerings and novel drugs key trends in the CRO space
In this snapshot from the J.P. Morgan Healthcare Conference, Steve Cutler comments on ICON’s success in decentralised trials and therapeutic technologies such as mRNA and checkpoint inhibitors.
ICON issues financial guidance for 2022 as the CRO giant eyes spike in revenue growth
This article discusses ICON’s forecast revenues for 2022 and includes a statement from Steve Cutler on ICON’s successes from 2021.
The personalised medicine paradigm
Cindy Spittle shares insights on the growth of molecular diagnostic testing in clinical trials.
Estimands: bringing clarity and focus to research questions in clinical trials
ICON's biostatistics experts offer their insights on the role of estimands in clinical research.
Sharing clinical trial results with paediatric participants
Kirsten Sherman Cervati contributes to this media article which discusses the considerations for returning results to paediatric participants.
Resisting change: The pathway to better AMR planning
Caroline Forkin, Vice President for Clinical Research Services, offers her insights on the various actions that should be taken to improve AMR planning.
In-Home Services: A patient-centric approach to improving recruitment and retention in clinical trials
An interview with Jodie Huddleston, Vice President Accellacare In-Home Services on the use of hybrid and decentralised models as viable solutions in clinical trial design.